romiplostim
amgen,kyowa kirin
great #ims2022 presentation by of what s to come in terms of bcma car-t toxicity management. g-csf likely not as scary as we thought, vs infections which are (hence ivig) note: eltrombopag is here but not romiplostim - latter might have pill burden and lft issues? 
Asst Professor @UWMedicine @fredhutch, s/p @UCSFCancer heme/onc ?? CAR-T training. #MMsm #TcellRx #cellphonesandcelltherapies ????

COI: https://t.co/3Uuojuio6R